Low-dose metabolism of benzene in humans: Science and obfuscation

Carcinogenesis

Volumn 34, Issue 1, 2013, Pages 2-9

  Rappaport, Stephen M ^a   Kim, Sungkyoon ^b   Thomas, Reuben ^a   Johnson, Brent A ^c   Bois, Frederic Y ^d,e   Kupper, Lawrence L ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Seoul National University   (South Korea)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^e INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

^f University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; PHENOL DERIVATIVE;

AIR MONITORING; AIR POLLUTANT; BIOLOGICAL MONITORING; BLOOD TOXICITY; BODY MASS; COMBUSTION; HUMAN; LUNG CLEARANCE; METABOLITE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; URINARY EXCRETION;

AIR POLLUTANTS, OCCUPATIONAL; BENZENE; ENVIRONMENTAL MONITORING; HUMANS; MODELS, STATISTICAL; OCCUPATIONAL EXPOSURE;

EID: 84872139241     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs382     Document Type: Review

References (54)

1. IARC. (2012) Chemical Agents and Related Occupations, Volume 100 F, A Review of Human Carcinogens. International Agency for Research on Cancer, Lyon, France.
2. Lan,Q. et al. (2004) Hematotoxicity in workers exposed to low levels of benzene. Science, 306, 1774-1776.
3. Schnatter,A.R. et al. (2012) Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis. J. Natl. Cancer Inst. J Natl Cancer Inst. 2012 Nov 21;104(22):1724-37. doi: 10.1093/jnci/djs411. Epub 2012 Oct 30.
4. Weisel,C.P. (2010) Benzene exposure: an overview of monitoring methods and their findings. Chem. Biol. Interact., 184, 58-66.
5. Ross,D. (2000) The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues. J. Toxicol. Environ. Health Part A, 61, 357-372.
6. Snyder,R. (2004) Xenobiotic metabolism and the mechanism(s) of benzene toxicity. Drug Metab. Rev., 36, 531-547.
7. Smith,M.T. et al. (2011) Benzene, the exposome and future investigations of leukemia etiology. Chem. Biol. Interact., 192, 155-159.
8. Waidyanatha,S. et al. (2005) Investigation of cysteinyl protein adducts of benzene diolepoxide. Chem. Biol. Interact., 153-154, 261-266.
9. Waidyanatha,S. et al. (2004) Rapid determination of six urinary benzene metabolites in occupationally exposed and unexposed subjects. Anal. Biochem., 327, 184-199.
10. Bone,E. et al. (1976) The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am. J. Clin. Nutr., 29, 1448-1454.
11. Carmella,S.G. et al. (1982) Quantitative analysis of catechol and 4-methylcatechol in human urine. Food Chem. Toxicol., 20, 587-590.
12. Deisinger,P.J. et al. (1996) Human exposure to naturally occurring hydroquinone. J. Toxicol. Environ. Health, 47, 31-46.
13. McDonald,T.A. et al. (2001) Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia, 15, 10-20.
14. Rothman,N. et al. (1998) Urinary excretion of phenol, catechol, hydroquinone, and muconic acid by workers occupationally exposed to benzene. Occup. Environ. Med., 55, 705-711.
15. Waidyanatha,S. et al. (2001) Urinary benzene as a biomarker of exposure among occupationally exposed and unexposed subjects. Carcinogenesis, 22, 279-286.
16. Melikian,A.A. et al. (2002) Personal exposure to different levels of benzene and its relationships to the urinary metabolites S-phenylmercapturic acid and trans,trans-muconic acid. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 778, 211-221.
17. Qu,Q. et al. (2000) Validation of biomarkers in humans exposed to benzene: urine metabolites. Am. J. Ind. Med., 37, 522-531.
18. Kim,S. et al. (2006) Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. Carcinogenesis, 27, 772-781.
19. Kim,S. et al. (2006) Modeling human metabolism of benzene following occupational and environmental exposures. Cancer Epidemiol. Biomarkers Prev., 15, 2246-2252.
20. Kim,S. et al. (2007) Genetic polymorphisms and benzene metabolism in humans exposed to a wide range of air concentrations. Pharmacogenet. Genomics, 17, 789-801.
21. Rappaport,S.M. et al. (2002) Non-linear production of benzene oxide-albumin adducts with human exposure to benzene. J. Chromatog. B, 778, 367-374.
22. Rappaport,S.M. et al. (2002) Albumin adducts of benzene oxide and 1,4-benzoquinone as measures of human benzene metabolism. Cancer Res., 62, 1330-1337.
23. Lin,Y.S. et al. (2007) Albumin adducts of electrophilic benzene metabolites in benzene-exposed and control workers. Environ. Health Perspect., 115, 28-34.
24. Johnson,B.A. et al. (2005) Modeling exposure-biomarker relationships: applications of linear and nonlinear toxicokinetics for understanding genotoxic metabolism and carcinogenesis. J. Agric. Biol. Environ. Stat., 10, 440-459.
25. Johnson,B.A. et al. (2007) On modelling metabolism-based biomarkers of exposure: a comparative analysis of nonlinear models with few repeated measurements. Stat. Med., 26, 1901-1919.
26. Taylor,D.J. et al. (2008) Statistical methods for evaluating exposure-biomarker relationships. J. Agric. Bio. Environ. Stat., 14, 367-387.
27. Bois,F.Y. et al. (1991) Comparison of three physiologically based pharmacokinetic models of benzene disposition. Toxicol. Appl. Pharmacol., 110, 79-88.
28. Bois,F.Y. et al. (1996) Population toxicokinetics of benzene. Environ. Health Perspect., 104 (suppl. 6), 1405-1411.
29. Travis,C.C. et al. (1990) Pharmacokinetics of benzene. Toxicol. Appl. Pharmacol., 102, 400-420.
30. Watanabe,K.H. et al. (1994) Benzene toxicokinetics in humans: exposure of bone marrow to metabolites. Occup. Environ. Med., 51, 414-420.
31. Weisel,C.P. et al. (2003) Use of stable isotopically labeled benzene to evaluate environmental exposures. J. Expo. Anal. Environ. Epidemiol., 13, 393-402.
32. Rappaport,S.M. et al. (2009) Evidence that humans metabolize benzene via two pathways. Environ. Health Perspect., 117, 946-952.
33. Rappaport,S.M. et al. (2010) Human benzene metabolism following occupational and environmental exposures. Chem. Biol. Interact., 184, 189-195.
34. Price,P.S. et al. (2012) A reanalysis of the evidence for increased efficiency in benzene metabolism at airborne exposure levels below 3 p.p.m. Carcinogenesis, 33, 2094-2099.
35. Aitchison,J. et al. (1957) The Lognormal Distribution. Cambridge University Press, London.
36. Crow,E.L. et al.. (eds.) (1988) Lognormal Distributions: Theory and Applications. Marcel Dekker, New York.
37. Kromhout,H. et al. (1993) A comprehensive evaluation of within- and between-worker components of occupational exposure to chemical agents. Ann. Occup. Hyg., 37, 253-270.
38. Lin,Y.S. et al. (2005) Air samples versus biomarkers for epidemiology. Occup. Environ. Med., 62, 750-760.
39. Rappaport,S.M. et al. (2008) Quantitative Exposure Assessment. Stephen Rappaport, El Cerrito, California.
40. Miller,D.M. (1984) Reducing transformation bias in curve fitting. The American Statistician, 38, 124-126.
41. Harrell,F.E. (2001) Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer, New York.
42. Ghittori,S. et al. (1993) Urinary excretion of unmetabolized benzene as an indicator of benzene exposure. J. Toxicol. Environ. Health, 38, 233-243.
43. Ghittori,S. et al. (1995) Evaluation of occupational exposure to benzene by urinalysis. Int. Arch. Occup. Environ. Health, 67, 195-200.
44. Fustinoni,S. et al. (1999) Headspace solid-phase microextraction for the determination of benzene, toluene, ethylbenzene and xylenes in urine. J. Chromatogr. B Biomed. Sci. Appl., 723, 105-115.
45. Fustinoni,S. et al. (2005) Urinary t,t-muconic acid, S-phenylmercapturic acid and benzene as biomarkers of low benzene exposure. Chem. Biol. Interact., 153-154, 253-256.
46. Neuman,S. (2003) Maximum likelihood Bayesian averaging of uncertain model predictions. Stochastic Environmental Research and Risk Assessment, 17, 291-305.
47. Durrleman,S. et al. (1989) Flexible regression models with cubic splines. Stat. Med., 8, 551-561.
48. Gibaldi,M. et al. (1982) Pharmacokinetics. 2nd edn, revised and expanded. Marcel Dekker, New York.
49. Andersen,M.E. (1981) Saturable metabolism and its relationship to toxicity. Crit. Rev. Toxicol., 9, 105-150.
50. Yokley,K. et al. (2006) Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach. Risk Anal., 26, 925-943.
51. Egeghy,P.P. et al. (2002) Self-collected breath sampling for monitoring low-level benzene exposures among automobile mechanics. Ann. Occup. Hyg., 46, 489-500.
52. Hunter,C.G. et al. (1972) Benzene: pharmacokinetic studies in man. Ann. Occup. Hyg., 15, 193-201.
53. Nomiyama,K. et al. (1974) Respiratory retention, uptake and excretion of organic solvents in man. Int. Arch. Arbeitsmed., 32, 75-83.
54. Pekari,K. et al. (1992) Biological monitoring of occupational exposure to low levels of benzene. Scand. J. Work. Environ. Health, 18, 317-322.